Jakob Dupont, SVP & Chief Medical Officer at OncoMed Pharmaceuticals Inc (OMED), sold 1,500 shares at $27.17 ($41K) on 2015-03-10, disclosed to the SEC on 2015-03-12.
Scheduled sale ($41k) by SVP & Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ATRA | SELL | 2022-11-18 | $19K | — | Filing → |
| ATRA | SELL | 2022-08-18 | $21K | — | Filing → |
| ATRA | SELL | 2022-05-19 | $21K | — | Filing → |